Crossmark Global Holdings Inc. Cuts Stock Position in Genpact Limited (NYSE:G)

Crossmark Global Holdings Inc. decreased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 1.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 389,739 shares of the business services provider's stock after selling 6,525 shares during the quarter. Crossmark Global Holdings Inc. owned about 0.22% of Genpact worth $19,635,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of G. Atlas Capital Advisors Inc. lifted its position in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after acquiring an additional 216 shares during the period. Stifel Financial Corp raised its position in Genpact by 1.0% during the 4th quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock worth $1,324,000 after purchasing an additional 291 shares during the last quarter. Fifth Third Bancorp increased its position in Genpact by 9.5% during the 1st quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock valued at $174,000 after purchasing an additional 299 shares during the period. KBC Group NV lifted its stake in shares of Genpact by 4.7% in the 1st quarter. KBC Group NV now owns 7,266 shares of the business services provider's stock valued at $366,000 after purchasing an additional 324 shares during the period. Finally, Callan Capital LLC boosted its holdings in shares of Genpact by 2.9% during the 1st quarter. Callan Capital LLC now owns 12,312 shares of the business services provider's stock worth $620,000 after buying an additional 351 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Genpact

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director directly owned 2,000 shares in the company, valued at $87,940. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 3.07% of the stock is owned by corporate insiders.

Genpact Price Performance

Shares of NYSE:G traded down $0.39 during mid-day trading on Thursday, reaching $45.30. The stock had a trading volume of 1,045,069 shares, compared to its average volume of 1,414,690. The business's 50 day moving average price is $44.12 and its 200 day moving average price is $47.00. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. The company has a market cap of $7.92 billion, a P/E ratio of 15.46, a price-to-earnings-growth ratio of 2.01 and a beta of 0.94.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The business's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $0.73 earnings per share. Research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Wednesday, June 18th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date was Wednesday, June 18th. Genpact's dividend payout ratio (DPR) is 23.21%.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Mizuho raised their price objective on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Needham & Company LLC restated a "buy" rating and issued a $50.00 price objective on shares of Genpact in a research report on Monday, June 30th. Finally, Robert W. Baird decreased their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Genpact presently has an average rating of "Moderate Buy" and an average target price of $50.14.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.